media

Markets

Market Nav

INCOME STATEMENT

You can view the income statement for the last 5 years.
Beryl Drugs Ltd.
( in Crs.)

ParticularsMar 18Mar 17
Months1212
Source Of Info (AR = Annual Report, PR = Press Release)PRPR
FaceValue10.0010.00
   
   
INCOME  
Revenue From Operations [Net]15.2511.27
Other Operating Revenues0.740.26
Total Operating Revenues15.9911.53
Total Revenue15.9911.53
   
EXPENSES  
Cost Of Materials Consumed8.916.94
Changes In Inventories Of FG,WIP And Stock-In Trade0.45-0.45
Employee Benefit Expenses0.730.98
Finance Costs0.130.20
Depreciation And Amortisation Expenses0.330.38
Other Expenses4.213.84
Total Expenses14.7611.89
   
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax1.23-0.36
   
Profit/Loss Before Tax1.23-0.36
   
Tax Expenses-Continued Operations  
Current Tax0.230.05
Total Tax Expenses0.230.05
Profit/Loss After Tax And Before ExtraOrdinary Items0.99-0.41
   
Profit/Loss From Continuing Operations0.99-0.41
   
Profit/Loss For The Period0.99-0.41
Consolidated Profit/Loss After MI And Associates0.99-0.41
   
OTHER INFORMATION  
   
EARNINGS PER SHARE  
Basic EPS (Rs.)1.960.00
Diluted EPS (Rs.)1.960.00
ParticularsMar 18
Months12
Source Of Info (AR = Annual Report, PR = Press Release)PR
FaceValue10.00
  
INCOME 
Revenue From Operations [Net]15.25
Other Operating Revenues0.74
Total Operating Revenues15.99
Total Revenue15.99
EXPENSES 
Cost Of Materials Consumed8.91
Changes In Inventories Of FG,WIP And Stock-In Trade0.45
Employee Benefit Expenses0.73
Finance Costs0.13
Depreciation And Amortisation Expenses0.33
Other Expenses4.21
Total Expenses14.76
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax1.23
Profit/Loss Before Tax1.23
Tax Expenses-Continued Operations 
Current Tax0.23
Total Tax Expenses0.23
Profit/Loss After Tax And Before ExtraOrdinary Items0.99
Profit/Loss From Continuing Operations0.99
Profit/Loss For The Period0.99
Consolidated Profit/Loss After MI And Associates0.99
OTHER INFORMATION 
EARNINGS PER SHARE 
Basic EPS (Rs.)1.96
Diluted EPS (Rs.)1.96